Dendritic Cell-Mediated Th2 Immunity and Immune Disorders S Kumar, Y Jeong, MU Ashraf, YS Bae International journal of molecular sciences 20 (9), 2159, 2019 | 100 | 2019 |
COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform MU Ashraf, Y Kim, S Kumar, D Seo, M Ashraf, YS Bae Vaccines 9 (2), 171, 2021 | 57 | 2021 |
Immunotherapeutic Potential of m6A-Modifiers and microRNAs in Controlling Acute Myeloid Leukaemia S Kumar, R Nagpal, A Kumar, MU Ashraf, YS Bae Biomedicines 9 (6), 690, 2021 | 24 | 2021 |
Factors responsible for the continuous persistence and evolution of low pathogenic avian influenza virus (H9N2) MU Ashraf, MS Mahmood World's Poultry Science Journal 73 (4), 791-802, 2017 | 12 | 2017 |
Epitranscriptomic Approach: To Improve the Efficacy of ICB Therapy by Co-targeting Intracellular Checkpoint CISH S Kumar, P Sarthi, I Mani, MU Ashraf, MH Kang, V Kumar, YS Bae Cells 10 (9), 2250, 2021 | 10 | 2021 |
Therapeutic Potential of microRNA Against Th2-associated Immune Disorders S Kumar, MU Ashraf, A Kumar, YS Bae Current Topics in Medicinal Chemistry 21, 753-766, 2021 | 10 | 2021 |
Role of cytosine-phosphate-guanosine-Oligodeoxynucleotides (CpG ODNs) as adjuvant in poultry vaccines MU Ishaq, A Rafique, HMN Cheema, MU Ashraf, SU Rahman, RZ Abbas, ... World's Poultry Science Journal 74 (3), 453-462, 2018 | 9 | 2018 |
Transendothelial migration (TEM) of in vitro generated dendritic cell vaccine in cancer immunotherapy MU Ashraf, Y Jeong, SE Roh, YS Bae Archives of pharmacal research 42, 582-590, 2019 | 4 | 2019 |
Advances in Personalized Therapy: Co-targeting Intracellular Immune checkpoints in Controlling Acute Myeloid Leukemia S Kumar, MU Ashraf, AK Aman, YS Bae Recent Developments in Medicine and Medical Research Vol. 14 14, 108-151, 2021 | 1 | 2021 |
Immunotherapeutic Potential of m6A-Modifiers in Controlling Acute Myeloid Leukemia S Kumar, R Nagpal, A Kumar, MU Ashraf, YS Bae Preprints, 2021 | 1 | 2021 |